Neurodevelopmental disorder
MONDO:0700092A behavioral and cognitive disorder with onset during the developmental period that involves impaired or aberrant development of intellectual, motor, or social functions.
1133 clinical trials for this condition and its sub-types, 161 tagged with Neurodevelopmental disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Neurodevelopmental disorder
-
Complex neurodevelopmental disorder 3 trials · 875 incl. sub-types
15 sub-types
- Pervasive developmental disorder 21 trials · 740 incl. sub-types Sub-types →
- Developmental and epileptic encephalopathy 29 trials · 98 incl. sub-types Sub-types →
- Prader-Willi syndrome 32 trials Sub-types →
- Complex neurodevelopmental disorder with motor features 1 trial · 10 incl. sub-types Sub-types →
- GRIN-related complex neurodevelopmental disorder 2 trials Sub-types →
- AFG2B-related complex neurodevelopmental disorder with motor features and hearing loss 0 trials
- DEAF1-associated neurodevelopmental disorder 0 trials Sub-types →
- NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability 0 trials
- X-linked complex neurodevelopmental disorder 0 trials Sub-types →
- Complex neurodevelopmental disorder with or without congenital anomalies 0 trials Sub-types →
- Intellectual disability, autosomal dominant 29 0 trials
- Neonatal encephalopathy with non-epileptic myoclonus 0 trials
- Neurodevelopmental disorder with language impairment and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with severe motor impairment and absent language 0 trials
- Syndromic complex neurodevelopmental disorder 0 trials Sub-types →
-
Mendelian neurodevelopmental disorder 0 trials · 208 incl. sub-types
275 sub-types
- Genetic developmental and epileptic encephalopathy 2 trials · 83 incl. sub-types Sub-types →
- Prader-Willi syndrome 32 trials Sub-types →
- Rett syndrome 31 trials
- Intellectual disability, autosomal dominant 0 trials · 23 incl. sub-types Sub-types →
- X-linked intellectual disability 1 trial · 15 incl. sub-types Sub-types →
- CACNA1A-related complex neurodevelopmental disorder 1 trial · 9 incl. sub-types Sub-types →
- Autosomal recessive primary microcephaly 0 trials · 8 incl. sub-types Sub-types →
- Smith-Magenis syndrome 5 trials
- Rubinstein-Taybi syndrome 3 trials Sub-types →
- Alternating hemiplegia of childhood 3 trials Sub-types →
- FOXG1 disorder 2 trials
- GRIN-related complex neurodevelopmental disorder 2 trials Sub-types →
- Neurodevelopmental disorder with involuntary movements 2 trials
- CAMK2D-related neurodevelopmental disorder and dilated cardiomyopathy 1 trial
- Dyneinopathy 0 trials · 1 incl. sub-types Sub-types →
- Intellectual disability, autosomal recessive 0 trials · 1 incl. sub-types Sub-types →
- Microcephalic osteodysplastic primordial dwarfism type I 1 trial
- Microcephalic osteodysplastic primordial dwarfism type II 1 trial
- Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 1 trial
- Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 1 trial
- Orofaciodigital syndrome I 1 trial
- AFG2B-related complex neurodevelopmental disorder with motor features and hearing loss 0 trials
- AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0 trials
- ARF3-related neurodevelopmental disorder 0 trials
- ATXN7L3-related developmental delay, hypotonia and facial dysmorphism 0 trials
- Alzahrani-Kuwahara syndrome 0 trials
- Amish lethal microcephaly 0 trials
- Au-Kline syndrome 0 trials
- Brunet-Wagner neurodevelopmental syndrome 0 trials
- CBX1-related neurodevelopmental disorder 0 trials
- CK syndrome 0 trials
- CNOT9-related developmental disorder with seizures 0 trials
- CTR9-related neurodevelopmental disorder 0 trials
- Chilton-Okur-Chung neurodevelopmental syndrome 0 trials
- DDX17-related neurodevelopmental disorder 0 trials
- DEAF1-associated neurodevelopmental disorder 0 trials Sub-types →
- DIP2C-related developmental disorder with speech delay 0 trials
- Delpire-McNeill syndrome 0 trials
- Dentici-Novelli neurodevelopmental syndrome 0 trials
- Dursun-Ozgul neurodevelopmental syndrome 0 trials
- Dworschak-Punetha neurodevelopmental syndrome 0 trials
- EPB41L3-related developmental disorder with delayed myelination and seizures 0 trials
- El Hayek-Chahrour neurodevelopmental disorder 0 trials
- FAT4-related neurodevelopmental disorder 0 trials
- FEZF2-related neurodevelopmental disorder 0 trials
- Ferguson-Bonni neurodevelopmental syndrome 0 trials
- GABRA4-related neurodevelopmental disorder with seizures 0 trials
- GABRD-related neurodevelopmental disorder with epilepsy 0 trials
- HDAC3-related neurodevelopmental disorder 0 trials
- HMGB1-related brachyphalangy, polydactyly and tibial aplasia syndrome 0 trials
- HNRNPC-related neurodevelopmental disorder 0 trials Sub-types →
- Hao-Fountain syndrome due to USP7 mutation 0 trials
- Harel-Tora neurodevelopmental syndrome 0 trials
- Harel-Yoon syndrome 0 trials
- Hiatt-Neu-Cooper neurodevelopmental syndrome 0 trials
- Houge-Janssens syndrome 3 0 trials
- Jeffries-Lakhani neurodevelopmental syndrome 0 trials
- KCND2-related neurodevelopmental disorder with or without seizures 0 trials
- KCNH1 associated disorder 0 trials Sub-types →
- KCNK3-related developmental delay with sleep apnea 0 trials
- KDM2B-related neurodevelopmental disorder 0 trials
- Karayol-Borroto-Haghshenas neurodevelopmental syndrome 0 trials
- Kariminejad neurodevelopmental syndrome 0 trials
- Li-Takada-Miyake syndrome 0 trials
- MYCBP2-related developmental delay with corpus callosum defects 0 trials
- MYH10-related neurodevelopmental disorder with congenital anomalies 0 trials
- Marbach-Schaaf neurodevelopmental syndrome 0 trials
- NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability 0 trials
- Nil-Deshwar neurodevelopmental syndrome 0 trials
- Okur-Chung neurodevelopmental syndrome 0 trials
- PAX5-related B lymphopenia and autism spectrum disorder 0 trials
- PIP5K1C-related neurodevelopmental disorder 0 trials
- PPFIA3-related neurodevelopmental disorder 0 trials
- PPP2R1A-related intellectual disability 0 trials
- PRPF19-related neurodevelopmental disorder 0 trials
- Pitt-Hopkins-like syndrome 2 0 trials
- Poirier-Bienvenu neurodevelopmental syndrome 0 trials
- Popov-Chang syndrome 0 trials
- RFX3-related neurodevelopmental disorder with autism and other behavioural abnormalities 0 trials
- RFX4-related neurodevelopmental disorder with autism and other behavioural abnormalities 0 trials
- RNU5B-1 related neurodevelopmental disorder with seizures and joint laxity 0 trials
- Ramond-Elliott neurodevelopmental syndrome 0 trials
- SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth 0 trials Sub-types →
- SOX11-related complex neurodevelopmental disorder with or without congenital anomalies 0 trials
- SYNCRIP-related neurodevelopmental disorder 0 trials
- Stankiewicz-Isidor syndrome 0 trials
- TRA2B-related neurodevelopmental disorder 0 trials
- WDR5-related neurodevelopmental disorder 0 trials
- Wieacker-Wolff syndrome 0 trials
- X-linked complex neurodevelopmental disorder 0 trials Sub-types →
- Aplasia cutis-enamel dysplasia syndrome 0 trials
- Autosomal dominant primary microcephaly 0 trials Sub-types →
- Cerebellar atrophy, visual impairment, and psychomotor retardation; 0 trials
- Cerebral palsy, spastic quadriplegic, 2 0 trials
- Cerebral palsy, spastic quadriplegic, 3 0 trials
- Complex cortical dysplasia with other brain malformations 5 0 trials
- Developmental delay and seizures with or without movement abnormalities 0 trials
- Developmental delay with autism spectrum disorder and gait instability 0 trials
- Developmental delay with variable intellectual impairment and behavioral abnormalities 0 trials
- Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 0 trials
- Intellectual developmental disorder and retinitis pigmentosa; IDDRP 0 trials
- Intellectual developmental disorder with polymicrogyria and seizures 0 trials
- Intellectual disability, autosomal dominant 29 0 trials
- Microcephalic osteodysplastic primordial dwarfism, type 3 0 trials
- Microcephaly and chorioretinopathy 0 trials Sub-types →
- Microcephaly with lissencephaly and/or hydranencephaly 0 trials Sub-types →
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia 0 trials
- Neurocardiorenal malformation syndrome 0 trials
- Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity 0 trials
- Neurodevelopmental disorder plus optic atrophy 0 trials
- Neurodevelopmental disorder with absent language and variable seizures 0 trials
- Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with achalasia, polyneuropathy, and alacrima 0 trials
- Neurodevelopmental disorder with alopecia and brain abnormalities 0 trials
- Neurodevelopmental disorder with ataxia and brain abnormalities 0 trials
- Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly 0 trials
- Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 0 trials
- Neurodevelopmental disorder with behavioral abnormalities and childhood-onset spastic paraplegia 0 trials
- Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 0 trials
- Neurodevelopmental disorder with behavioral, ear, and skeletal abnormalities 0 trials
- Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies 0 trials
- Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities 0 trials
- Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with central and peripheral motor dysfunction 0 trials
- Neurodevelopmental disorder with central hypotonia and dysmorphic facies 0 trials Sub-types →
- Neurodevelopmental disorder with cerebellar atrophy and with or without seizures 0 trials
- Neurodevelopmental disorder with cerebellar hypoplasia and spasticity 0 trials
- Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism 0 trials
- Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1 0 trials
- Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 0 trials
- Neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities 0 trials
- Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 0 trials
- Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia 0 trials
- Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0 trials
- Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 0 trials
- Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia 0 trials
- Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum 0 trials
- Neurodevelopmental disorder with dysmorphic facies and variable seizures 0 trials
- Neurodevelopmental disorder with dysmorphic facies, absent speech and ambulation, and brain abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies, brain anomalies, and seizures 0 trials
- Neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia 0 trials
- Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities 0 trials
- Neurodevelopmental disorder with dystonia and seizures 0 trials
- Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with early-onset seizures, facial dysmorphism, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with epilepsy and brain atrophy 0 trials
- Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 0 trials
- Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0 trials
- Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy 0 trials
- Neurodevelopmental disorder with eye movement abnormalities and ataxia 0 trials
- Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly 0 trials
- Neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 0 trials
- Neurodevelopmental disorder with growth impairment, quadriparesis, and poor or absent speech 0 trials
- Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities 0 trials
- Neurodevelopmental disorder with hearing loss and spasticity 0 trials
- Neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0 trials
- Neurodevelopmental disorder with hyperkinetic movements, seizures, and structural brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements 0 trials
- Neurodevelopmental disorder with hypotonia and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia and characteristic brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and dysmorphic facies 0 trials
- Neurodevelopmental disorder with hypotonia and gross motor and speech delay 0 trials
- Neurodevelopmental disorder with hypotonia and seizures 0 trials
- Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, brain anomalies, distinctive facies, and absent language 0 trials
- Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, epilepsy, and absent speech 0 trials
- Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, feeding difficulties, facial dysmorphism, and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia, microcephaly, and seizures 0 trials
- Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation 0 trials
- Neurodevelopmental disorder with hypotonia, neuropathy, and deafness 0 trials
- Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia 0 trials
- Neurodevelopmental disorder with hypotonia, seizures, and absent language 0 trials
- Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0 trials
- Neurodevelopmental disorder with impaired language and ataxia and with or without seizures 0 trials
- Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with impaired speech and hyperkinetic movements 0 trials
- Neurodevelopmental disorder with infantile epileptic spasms 0 trials
- Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies 0 trials
- Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity 0 trials
- Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 0 trials
- Neurodevelopmental disorder with language delay and seizures 0 trials
- Neurodevelopmental disorder with language delay and variable cognitive abnormalities 0 trials
- Neurodevelopmental disorder with language impairment and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder 0 trials
- Neurodevelopmental disorder with microcephaly and dysmorphic facies 0 trials
- Neurodevelopmental disorder with microcephaly and movement abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly and structural brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, absent speech, and hypotonia 0 trials
- Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, ataxia, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 0 trials
- Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity 0 trials
- Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0 trials
- Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis 0 trials
- Neurodevelopmental disorder with microcephaly, short stature, and speech delay 0 trials
- Neurodevelopmental disorder with midbrain and hindbrain malformations 0 trials
- Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism 0 trials
- Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities 0 trials
- Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction 0 trials
- Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features 0 trials
- Neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0 trials
- Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0 trials
- Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 0 trials
- Neurodevelopmental disorder with or without autism or seizures 0 trials
- Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities 0 trials
- Neurodevelopmental disorder with or without early-onset generalized epilepsy 0 trials
- Neurodevelopmental disorder with or without seizures and gait abnormalities 0 trials
- Neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0 trials
- Neurodevelopmental disorder with poor growth and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with poor growth and skeletal anomalies 0 trials
- Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with poor growth, seizures, and brain abnormalities 0 trials
- Neurodevelopmental disorder with poor language and loss of hand skills 0 trials
- Neurodevelopmental disorder with poor or absent speech, dysmorphic facies, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0 trials
- Neurodevelopmental disorder with progressive movement abnormalities 0 trials
- Neurodevelopmental disorder with progressive spasticity and brain abnormalities 0 trials
- Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities 0 trials
- Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 0 trials
- Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies 0 trials
- Neurodevelopmental disorder with seizures and brain atrophy 0 trials
- Neurodevelopmental disorder with seizures and gingival overgrowth 0 trials
- Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 0 trials
- Neurodevelopmental disorder with seizures and speech and walking impairment 0 trials
- Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities 0 trials
- Neurodevelopmental disorder with seizures, hypotonia, and variable spasticity 0 trials
- Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0 trials
- Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0 trials
- Neurodevelopmental disorder with severe motor impairment and absent language 0 trials
- Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy 0 trials
- Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 0 trials
- Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 0 trials
- Neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies 0 trials
- Neurodevelopmental disorder with spasticity and poor growth 0 trials
- Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 0 trials
- Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities 0 trials
- Neurodevelopmental disorder with spasticity, thin corpus callosum, and decreased brain white matter 0 trials
- Neurodevelopmental disorder with speech delay and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with speech delay and variable ocular anomalies 0 trials
- Neurodevelopmental disorder with speech delay, movement abnormalities, and seizures 0 trials
- Neurodevelopmental disorder with speech impairment and dysmorphic facies 0 trials
- Neurodevelopmental disorder with speech impairment and with or without seizures 0 trials
- Neurodevelopmental disorder with speech or visual impairment and brain hypomyelination 0 trials
- Neurodevelopmental disorder with structural brain abnormalities and craniofacial abnormalities 0 trials
- Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies 0 trials
- Neurodevelopmental disorder with thin corpus callosum, hypotonia, and absent language 0 trials
- Neurodevelopmental disorder with variable familial hypercholanemia 0 trials
- Neurodevelopmental disorder with visual defects and brain anomalies 0 trials
- Neurodevelopmental disorder with white matter abnormalities and gait disturbance 0 trials
- Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 0 trials
- Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 0 trials
- Otofacial neurodevelopmental syndrome 0 trials
- Parenti-mignot neurodevelopmental syndrome 0 trials
- Squalene synthase deficiency 0 trials
-
Intellectual disability 138 trials · 175 incl. sub-types
10 sub-types
- Syndromic intellectual disability 2 trials · 38 incl. sub-types Sub-types →
- Intellectual disability, autosomal dominant 0 trials · 23 incl. sub-types Sub-types →
- X-linked intellectual disability 1 trial · 15 incl. sub-types Sub-types →
- Non-syndromic intellectual disability 0 trials · 10 incl. sub-types Sub-types →
- Intellectual disability, autosomal recessive 0 trials · 1 incl. sub-types Sub-types →
- NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability 0 trials
- PPP2R1A-related intellectual disability 0 trials
- SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth 0 trials Sub-types →
- Intellectual developmental disorder and retinitis pigmentosa; IDDRP 0 trials
- Intellectual developmental disorder with polymicrogyria and seizures 0 trials
-
Williams syndrome 18 trials
-
Microcephaly 4 trials · 13 incl. sub-types
10 sub-types
- Isolated congenital microcephaly 0 trials · 8 incl. sub-types Sub-types →
- Microcephalic osteodysplastic primordial dwarfism 1 trial Sub-types →
- Amish lethal microcephaly 0 trials
- Isolated microcephaly 0 trials
- Microcephaly and chorioretinopathy 0 trials Sub-types →
- Microcephaly with intellectual disability 0 trials Sub-types →
- Microcephaly with lissencephaly and/or hydranencephaly 0 trials Sub-types →
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia 0 trials
- Microcephaly, seizures, and developmental delay 0 trials
-
Atypical Rett syndrome 0 trials · 12 incl. sub-types
2 sub-types
- Developmental and epileptic encephalopathy, 2 10 trials
- FOXG1 disorder 2 trials
-
Alternating hemiplegia 0 trials · 3 incl. sub-types
2 sub-types
-
Aicardi syndrome 2 trials
-
Hao-Fountain syndrome 0 trials
2 sub-types
-
Toluene embryopathy 0 trials
Most studied deeper sub-types
-
Can a One-Time gene therapy fix the root cause of rett syndrome?
Cure By invitation onlyRett syndrome is a rare genetic disorder that mostly affects girls and stems from mutations in the MECP2 gene. This trial tests GCB-002, an experimental gene therapy given as a single injection into the spinal fluid, in 6 to 9 girls aged 2 to 10 who have a confirmed MECP2 mutatio…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
New enzyme therapy aims to reach the brain in hunter syndrome
Disease control OngoingResearchers are testing a new enzyme replacement therapy called GNR-055 in people with Hunter syndrome (MPS II), a rare inherited disorder that causes harmful sugar molecules to build up in the body. The trial enrolls about 32 patients, including those who have never had enzyme t…
Phase 2/3 • Sponsor: AO GENERIUM • Aim: Disease control
Last updated Sep 21, 2026 14:00 UTC
-
New hope for dravet syndrome: phase 3 trial of LP352 aims to cut seizure frequency
Disease control OngoingThis study tests whether the drug LP352 can safely reduce seizures in children and adults with Dravet syndrome, a severe form of epilepsy. About 160 participants will receive either LP352 or a placebo, and researchers will track changes in seizure frequency over several months. T…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for Hard-to-Treat seizures: phase 3 trial launches
Disease control OngoingThis study tests an experimental drug called LP352 to see if it can safely reduce seizures in children and adults with developmental and epileptic encephalopathies (DEE), a group of severe epilepsy syndromes. About 320 participants will receive either LP352 or a placebo, and rese…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy
Disease control OngoingThis study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Phase 2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control By invitation onlyThis phase 3 study is testing the long-term safety and effectiveness of LP352 (Bexicaserin) in 324 children and adults with developmental and epileptic encephalopathy (DEE), including Dravet and Lennox-Gastaut syndromes. Participants who completed earlier studies will receive LP3…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can lifestyle coaching and therapy protect autistic teens from heart disease?
Disease control By invitation onlyThis study tests two approaches—lifestyle medicine consultations and cognitive behavioral therapy (CBT)—to reduce cardiovascular risk in autistic individuals aged 9 to 26 who have a high body mass index. Participants are randomly assigned to receive lifestyle coaching, CBT sessio…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Gut bacteria may soothe autism symptoms in adults, small trial hints
Disease control OngoingThis study tests whether a probiotic called Lactobacillus plantarum can improve social interactions, reduce inflammation, and enhance quality of life in adults with autism spectrum disorder. Twelve participants take the probiotic for 8 weeks, with assessments including blood test…
Sponsor: Mackay Memorial Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Radioactive microspheres aimed at prostate cancer: early safety trial underway
Disease control OngoingThis early study tests the safety of TheraSphere PCa, tiny radioactive glass beads injected into the prostate to treat localized prostate cancer. The trial involves 36 men with favorable intermediate-risk cancer and aims to find the maximum safe radiation dose. Researchers will m…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug under observation for rare genetic disorder
Disease control By invitation onlyThis study follows about 200 people with Prader-Willi syndrome who are taking or starting VYKAT XR. Researchers will track side effects and how the drug affects their health over time. The goal is to gather more safety information, not to test if the drug cures the condition.
Sponsor: Soleno Therapeutics, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Gene therapy hope for toddlers with rett syndrome
Disease control OngoingThis study tests a one-time gene therapy called TSHA-102 in girls aged 2 to 4 with Rett syndrome, a severe genetic disorder. The therapy is given as a single injection into the spine. The main goal is to check if it is safe and tolerable, and to see early signs of whether it help…
Phase 3 • Sponsor: Taysha Gene Therapies, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could probiotics soothe tummies in kids with autism?
Disease control OngoingThis study tests whether a daily probiotic supplement can improve the balance of gut bacteria in children aged 3 to 7 who have autism and digestive issues like constipation or stomach pain. Over 6 months, 60 children will receive either the probiotic or a placebo. The main goal i…
Sponsor: ProbiSearch SL • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for kids with rare epilepsy: drug trial targets seizure control
Disease control OngoingThis study tests an investigational drug called relutrigine in 160 children with a severe form of epilepsy called developmental and epileptic encephalopathy (DEE). The goal is to see if the drug can safely reduce monthly seizure frequency compared to a placebo. After the initial …
Phase 3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a new drug tame severe childhood epilepsy?
Disease control OngoingThis trial is testing an experimental drug called PRAX-222 in children aged 2 to 18 who have a rare, severe form of epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug is safe and can reduce how often seizures happen. Participants will receive either PRAX…
Phase 1/2 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Gene therapy breakthrough? new trial targets rare brain disorder FOXG1
Disease control By invitation onlyThis early-stage trial tests a new gene therapy called FRF-001 for FOXG1 syndrome, a rare genetic disorder that affects brain development. The therapy is given as a single injection into the brain's fluid spaces. The study will include 12 children and adults and will check for sa…
Phase 1/2 • Sponsor: FOXG1 Research Foundation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a dopamine-blocking drug safely control tourette syndrome over years?
Disease control OngoingThis trial investigates the long-term safety of ecopipam, a drug that blocks dopamine D1 and D5 receptors, in children, adolescents, and adults with Tourette syndrome. Participants who completed a prior study may enroll and receive ecopipam for up to 24 weeks or longer. The main …
Phase 3 • Sponsor: Emalex Biosciences Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug ML-004 moves to safety testing in autism patients
Disease control OngoingThis study is testing the safety of an experimental drug called ML-004 in 120 adolescents and adults with autism spectrum disorder who have already completed a previous study. Participants will take ML-004 once daily, and researchers will monitor for side effects. The goal is to …
Phase 2 • Sponsor: MapLight Therapeutics • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New cancer drug IDE161 enters human testing
Disease control OngoingThis early-stage trial is testing a new drug called IDE161, alone or with the immunotherapy pembrolizumab, in adults with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the right dose, and get a first look at wheth…
Phase 1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can early parent coaching help infants with rare genetic disorders thrive?
Disease control By invitation onlyThis study tests a program called PIXI that coaches parents of infants diagnosed with rare neurogenetic disorders (such as Fragile X, Angelman, or Down syndrome) during the first year of life. The program combines education about the disorder, guided parent-child interaction acti…
Sponsor: RTI International • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New gene therapy hopes to restore milestones in rett syndrome
Disease control OngoingThis study tests a one-time gene therapy called TSHA-102 in females aged 6 to under 22 with classic Rett syndrome. The goal is to see if it is safe and can help them regain or gain new developmental skills like walking or talking. Participants receive the therapy through a spinal…
Phase 3 • Sponsor: Taysha Gene Therapies, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug could slow rare brain disease that steals balance
Disease control OngoingThis phase 3 trial tests whether the drug troriluzole can slow the progression of spinocerebellar ataxia, a rare genetic disorder that affects coordination and balance. About 300 adults with different types of SCA are randomly assigned to take either troriluzole or a placebo dail…
Phase 3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Tailored milk boosts preemie brain growth?
Disease control OngoingThis study compares two ways of fortifying breast milk for preterm babies in the NICU. One group gets standard fortification, while the other gets a personalized mix based on real-time milk analysis. Researchers will track growth, brain scans, and development up to age 2 to see w…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gene therapy trial aims to help girls with rett syndrome gain new skills
Disease control OngoingThis study tests a gene therapy called NGN-401 in 33 girls with Rett syndrome, a rare genetic disorder that affects development and movement. The therapy delivers a working copy of the MECP2 gene to try to improve skills and daily function. Researchers will measure success by whe…
Phase 3 • Sponsor: Neurogene Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could an HIV drug help treat rett syndrome?
Disease control By invitation onlyThis phase 2 trial tests whether lamivudine, an antiviral drug, can improve symptoms in people with Rett syndrome, a rare genetic disorder that affects movement, communication, and behavior. Ten participants will take the drug by mouth for a set period, and researchers will measu…
Phase 2 • Sponsor: Maria Denise Fernandes Carvalho de Andrade • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a drug slow rare brain disease? new study uses Real-World data to find out
Disease control OngoingThis study looks at whether the drug troriluzole can slow the progression of spinocerebellar ataxia (SCA), a rare genetic disease that affects movement and balance. Researchers will compare 909 patients who took troriluzole for up to three years with similar patients who did not …
Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Gene therapy trial aims to tame seizures in kids with rare epilepsy
Disease control OngoingThis early-stage study tests a gene therapy called ETX101 in 5 children with Dravet syndrome, a severe form of epilepsy. The therapy delivers a gene that helps calm overactive brain cells. Researchers will check if it safely reduces seizure frequency and improves thinking and dai…
Phase 1/2 • Sponsor: Encoded Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Autism drug trial pulled before it even started
Disease control CancelledThis study planned to test the drug bumetanide in children aged 5 to 17 with autism of known cause. The goal was to see if it could improve autism symptoms. However, the trial was withdrawn before enrolling any participants, so no new information was gathered.
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
CBD epilepsy drug under Real-World watch for rare seizure disorders
Disease control OngoingThis study follows about 111 people with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex who are taking Epidyolex (a CBD oral solution) for seizures. Researchers track how many stay on the drug for a year and how many seizure-free days they have. It's an o…
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
One-shot gene therapy aims to tame rett syndrome in young girls
Disease control OngoingThis early-phase trial tests a single injection of AAV-MECP2 gene therapy into the spinal fluid of 8 girls aged 4-10 with Rett syndrome, a severe neurodevelopmental disorder. The goal is to see if the treatment is safe and can reduce disease severity. The study is not yet recruit…
Early phase 1 • Sponsor: Guangzhou Women and Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can parent training ease autism symptoms in young children?
Disease control By invitation onlyThis study tests whether a structured parent training program can reduce autism symptoms in children up to age 5 and high-risk infants under 2. 250 children and their caregivers will be randomly assigned to receive either the training plus routine care, or routine care alone. Aft…
Sponsor: Umraniye Education and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New telehealth program helps parents of kids with autism tackle weight
Disease control OngoingThis study tests a telehealth program that teaches parents of children with autism and overweight or obesity how to help their child manage weight through nutrition, activity, and behavior skills. About 140 families will take part, with one group receiving the parent-based progra…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could stem cells and a special diet ease autism symptoms? new trial aims to find out.
Disease control By invitation onlyThis study tests whether a mix of treatments—including the patient's own stem cells, a strict keto diet, and a fecal transplant—can improve social skills, communication, and gut health in 50 teens and adults with autism. Participants must be stable on their current medications. T…
Phase 1/2 • Sponsor: Black Tie Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for rare epilepsy: drug shows promise in phase 3 trial
Disease control OngoingThis Phase 3 study tests whether fenfluramine (ZX008) can safely reduce seizures in 87 children and adults with CDKL5 deficiency disorder, a rare genetic condition causing severe epilepsy. Participants receive either the drug or a placebo, followed by an open-label extension wher…
Phase 3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a Vitamin-Like supplement boost language in kids with autism?
Disease control OngoingThis study tests whether leucovorin calcium, a vitamin-like supplement, can improve language and other symptoms in young children with autism spectrum disorder. Researchers will enroll 80 children aged 2.5 to 5 years with language delays. The trial lasts about 26 weeks and compar…
Phase 2 • Sponsor: Southwest Autism Research & Resource Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for rare epilepsy: fenfluramine made available for dravet patients
Disease control ApprovedThis study offers fenfluramine to people with Dravet syndrome whose seizures have not improved with other medications. The goal is to provide access to the drug and monitor its safety. Participants must have a genetic diagnosis of Dravet syndrome and have tried all available seiz…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Brain pacemaker shows promise for rare childhood epilepsy
Disease control OngoingThis pilot study tests whether deep brain stimulation (DBS) of specific brain pathways can safely reduce seizures in people with Lennox-Gastaut syndrome, a severe form of epilepsy. Five participants receive the electrical stimulation as an add-on to their usual treatment. The goa…
Sponsor: Liankun_Ren • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Nasal gene therapy offers new hope for brain injury patients
Disease control By invitation onlyThis study follows 25 people aged 2 to 65 with cerebral palsy or brain damage from lack of oxygen who have already received a new gene therapy given as a nose spray. The therapy delivers 15 genes meant to repair the brain, reduce inflammation, and improve movement and thinking. R…
Sponsor: Healing Hope International • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Autism drug CM-AT shows promise in reducing irritability
Disease control OngoingThis study tests a drug called CM-AT in children with autism who have low levels of a digestive enzyme. The goal is to see if the drug is safe and helps with behaviors like irritability and social withdrawal over a longer period. About 405 children aged 3 to 8 who completed a pre…
Phase 3 • Sponsor: Curemark • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug pitolisant tested for safety in rare genetic disorder
Disease control By invitation onlyThis phase 3 trial is testing the safety of pitolisant in 150 people with Prader-Willi syndrome who have already taken the drug in a previous study. Participants will receive pitolisant tablets and be monitored for side effects. The goal is to see if pitolisant is safe for long-t…
Phase 3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could an allergy drug boost brain function in williams syndrome?
Disease control OngoingThis phase 2 trial tests whether clemastine, a common allergy medication, can improve thinking, motor skills, and social abilities in people with Williams syndrome. The study includes 30 participants aged 6 to 30 and uses a double-blind, placebo-controlled design to measure safet…
Phase 2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Experimental drug shows promise for rare genetic syndrome in toddlers
Disease control OngoingThis phase 2 trial tests the drug tiratricol (Triac) in 22 young boys (up to 30 months old) with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome. The goal is to see if the drug can improve brain development and reduce harmful thyroid effects in the body. Participants…
Phase 2 • Sponsor: Rare Thyroid Therapeutics International AB • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Diabetes drug could help Babies' brains heal after birth injury
Disease control By invitation onlyThis early-stage trial tests whether metformin, a common diabetes drug, is safe and feasible for infants who suffered brain injury from lack of oxygen at birth. Thirty infants under 6 months old will receive metformin for 6 weeks, with close monitoring of kidney and liver functio…
Phase 1 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug aims to curb hunger in Prader-Willi syndrome
Disease control OngoingThis phase 2 trial tests setmelanotide (Imcivree), a daily injection, in 18 people aged 6 to 65 with Prader-Willi syndrome who have obesity. The study will check if the drug is safe and helps reduce body weight and hunger over 52 weeks.
Phase 2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Hope for dravet syndrome: Long-Term safety trial of STK-001 underway
Disease control OngoingThis study looks at the long-term safety of an experimental drug called zorevunersen (STK-001) in 60 people with Dravet syndrome, a severe form of epilepsy. Participants must have completed an earlier STK-001 study. Researchers will monitor side effects, seizure frequency, and qu…
Phase 2 • Sponsor: Stoke Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for kids with hard-to-treat genetic seizures
Disease control OngoingThis study tests a new medicine called PRAX-562 in 77 children with rare genetic epilepsies (SCN2A or SCN8A). The goal is to see if it safely reduces motor seizures. The trial has two parts: a double-blind phase where some children get the drug and some get a placebo, followed by…
Phase 2/3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for dravet syndrome: expanded access to seizure drug stiripentol
Disease control ApprovedThis program provides expanded access to the drug stiripentol for people aged 6 months and older with Dravet syndrome, a severe form of epilepsy. The goal is to help control seizures that do not respond to other treatments. Participants must have a confirmed diagnosis and meet sa…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a urea cycle drug help kids with rare epilepsy?
Disease control OngoingThis early-phase trial is testing whether glycerol phenylbutyrate (Ravicti), a drug already approved for a different condition, is safe and tolerable for children with genetic disorders like STXBP1 and SLC6A1 that cause seizures and developmental delays. The study will enroll 50 …
Early phase 1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gene therapy trial aims to tame severe seizures in kids with dravet syndrome
Disease control OngoingThis study tests a gene therapy called ETX101 in 4 children with Dravet syndrome, a severe seizure disorder caused by a gene change. The therapy uses a harmless virus to deliver a working copy of the gene to brain cells. The main goals are to see if it is safe and if it reduces s…
Phase 1/2 • Sponsor: Encoded Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Gene therapy hope for girls with rare brain disorder
Disease control OngoingThis study tests a new gene therapy called TSHA-102 for girls aged 5 to 8 with Rett syndrome, a severe genetic disorder that affects brain development. The therapy is given as a single injection into the spinal fluid. The main goal is to check safety and side effects, while also …
Phase 1/2 • Sponsor: Taysha Gene Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Custom drug targets rare genetic brain condition in one patient
Disease control OngoingThis study tests a custom-made drug called an antisense oligonucleotide (ASO) designed specifically for one person with a rare genetic brain disorder (NEDBA) caused by a MAPK8IP3 mutation. The goal is to see if the drug can improve motor skills and reduce seizures over 12 to 24 m…
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Bridge program keeps seizure drug available for eligible patients
Disease control Expanded access (ended)This program provides continued access to the seizure medication perampanel (Fycompa) for people who completed certain earlier studies and are still benefiting from the drug. It runs until the drug is commercially available in their country or no participants remain. Only those a…
Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
AI listens for signs of depression, autism, and more in your speech
Diagnosis By invitation onlyThis study is testing whether artificial intelligence can analyze a person's speech to help diagnose mental health conditions like depression, anxiety, autism, and schizophrenia. Researchers will record 500 people speaking and compare the AI's predictions to standard clinical dia…
Sponsor: Psyrin Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 12:40 UTC
-
Can a video-based therapy tame tough behaviors in kids with rare genetic disorders?
Symptom relief OngoingThis study tests a virtual behavioral therapy (Functional Behavioral Training) for children aged 2-12 with genetic syndromes like Fragile X, Angelman, or Rett syndrome who have challenging behaviors. The therapy teaches parents how to identify what triggers problem behaviors and …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can virtual reality boost thinking skills in kids with autism?
Symptom relief OngoingResearchers are testing whether occupational therapy that uses virtual reality can improve cognitive skills, daily performance, and motivation in children with autism. The study includes 32 children aged 6 to 12 with autism level 1. Half receive virtual reality-supported cognitiv…
Sponsor: Biruni University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can online CBT coaching ease anxiety in kids with autism?
Symptom relief OngoingThis study compares cognitive behavioral therapy (CBT) with online expert coaching to usual care for children aged 6-14 with autism who struggle with anxiety, irritability, or emotional outbursts. About 100 children and 50 therapists will take part. The goal is to see if the coac…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Training the Brain's CEO: a new program aims to help kids with autism plan, organize, and stay in control
Symptom relief OngoingThis trial tests a structured, group-based training program designed to improve executive function skills in elementary school children aged 9 to 12 with autism spectrum disorder. Over 12 weeks, children attend weekly sessions that teach planning, organization, time management, e…
Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New sleep program aims to help kids with autism sleep better
Symptom relief By invitation onlyThis study tests a behavioral sleep and circadian intervention for 50 school-aged children (6–12 years) with autism who have sleep problems. Parents receive 5 Zoom sessions over 12 weeks to learn strategies to improve their child's sleep. The goal is to see if the program is feas…
Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Magic mushroom compound tested for Hard-to-Treat depression in autism
Symptom relief OngoingThis early-stage study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can safely help autistic adults with depression that hasn't improved with other treatments. Twenty participants will receive two doses of psilocybin along with ab…
Phase 1 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
New study offers culturally tailored support for spanish-speaking families of autistic children
Symptom relief OngoingThis study tests a version of the RUBI parent training program that has been adapted for Spanish-speaking families of autistic children aged 2 to 9. About 120 parents will join eight online group sessions to learn practical strategies for managing challenging behaviors. Researche…
Sponsor: Baylor University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
A new approach to sex education for autistic adults: adaptive web-based program puts relationship skills to the test
Symptom relief OngoingThis trial tests a web-based sex and relationship education program called Our Love, Our Style (OLOS) for autistic young adults in South Korea. Participants start with either web-based learning alone or web-based learning plus group coaching. Based on their progress, non-responde…
Sponsor: Ewha Womans University • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can robot legs help Non-Walking kids join in at school?
Symptom relief By invitation onlyThis pilot study explores whether robot-assisted walking devices can be used in schools to help children who cannot walk independently. The devices attach to a walker and power leg movements, allowing children to stand and walk upright. The study aims to identify the best ways to…
Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New hope for non-verbal kids: play plus speech therapy boosts language
Symptom relief OngoingThis study tests whether adding a motor-sound intervention (PROMPT) to a play-based therapy (JASPER) helps minimally verbal children with autism speak more words and combine them into phrases. Fifty-six children aged 4-7 who use fewer than 20 words will receive either JASPER alon…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Tailored talk therapy shows promise for Non-Verbal kids with autism
Symptom relief OngoingThis study tests whether personalized sequences of behavioral interventions can help minimally verbal preschoolers with autism improve their language skills. Researchers will compare two teaching approaches—JASPER (play-based) and DTT (structured)—to see which works best for each…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Can lifestyle coaching for parents ease autism symptoms in kids?
Symptom relief OngoingThis study tests a 12-month education and health coaching program for parents of children ages 3-7 who were recently diagnosed with autism. The program focuses on lifestyle factors like diet, sleep, and environment. Researchers want to see if this approach helps reduce autism sym…
Sponsor: Documenting Hope Project • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New study aims to bring autism therapy to more kids through public system
Symptom relief OngoingThis study tests whether training early intervention providers in Reciprocal Imitation Training can help children with autism improve imitation and communication skills. The program involves 440 children and their caregivers, with providers learning simple strategies during play.…
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Bedtime stories for autism? Single-Child trial shows early gains
Symptom relief OngoingThis study tests whether listening to special audio fairy tales before sleep can improve speech, motor skills, and independence in a child with autism and central auditory processing disorder. The child stays at home with their mother, avoiding clinic stress. Early results from t…
Sponsor: Natalia Poluektova • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Fish oil compound tested as autism symptom treatment
Symptom relief OngoingThis study tests whether DHA, a key omega-3 fatty acid found in fish oil, can improve symptoms of autism in children and adolescents aged 5 to 17. Participants receive either DHA or a placebo daily for 12 weeks. Researchers also look at genes and urine markers related to DHA to u…
Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Online therapy could ease anxiety in autistic teens
Symptom relief OngoingThis study tests an internet-based cognitive behavioral therapy (CBT) program designed to help autistic adolescents aged 11-17 manage anxiety. The program, called LUNA-Adolescent, is parent-led and delivered online, making it easier for families who cannot access in-person therap…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could farm animals help young adults with autism break out of social isolation?
Symptom relief OngoingThis trial explores whether spending time on a farm with animals and nature can help socially withdrawn young adults (ages 18–30) with autism spectrum disorder. Participants take part in supervised group activities on a farm twice a week for 12 weeks. Researchers will interview p…
Sponsor: Kronoberg County Council • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can eye contact training help toddlers with autism? new trial tests Parent-Led therapy
Symptom relief OngoingThis study tests whether a parent-led therapy called Pathways can improve social skills in 80 toddlers (16-30 months old) who show early signs of autism. One group of parents learns a technique to encourage mutual eye contact during play, while the other group uses the same thera…
Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Virtual reality could calm anxious kids with autism at the dentist
Symptom relief By invitation onlyThis study tests whether wearing a virtual reality (VR) headset during dental treatment can reduce fear and stress in children with mild intellectual disabilities or autism spectrum disorder. Two hundred children aged 6 to 12 will either receive standard dental care or use a VR h…
Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can virtual reality help adults with autism connect better?
Symptom relief OngoingThis study tests a new virtual reality program designed to help adults with autism improve their social skills and daily functioning. 140 participants will either receive the VR training plus usual care, or usual care alone, for 3 months. Researchers will measure changes in socia…
Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can rewriting your life story improve mental health? small trial tests new therapy
Symptom relief OngoingThis study tests a therapy called RETELL that helps people with severe mental illness explore and reshape their life stories. The goal is to improve personal recovery, quality of life, and identity. Twenty adults with conditions like schizophrenia, bipolar disorder, or PTSD will …
Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New app aims to make toothbrushing easier for kids with autism
Symptom relief By invitation onlyThis study tests whether an autism-friendly mobile app can help children and teens (ages 8-17) with autism improve their toothbrushing skills and habits. Participants use either the special app or a basic control app for 3 months while researchers track brushing quality and habit…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Could a daily probiotic help adults with autism reach personal goals?
Symptom relief OngoingThis study tests whether a probiotic supplement called Neuralli® MP can help adults aged 18 to 50 who have autistic traits. Participants take two capsules daily and set their own personal goals to track progress. The trial is small and open-label, meaning everyone knows they are …
Sponsor: Mackay Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Pickleball power: new study tests sport as brain booster for teens with disabilities
Symptom relief OngoingThis study looks at whether playing pickleball for 12 weeks can improve thinking skills like attention and memory, as well as motor skills like balance and strength, in adolescents aged 14-18 with mild intellectual disability. Thirty-two students will either play pickleball three…
Sponsor: Elif Top • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Robotic exoskeleton training shows promise for kids with movement disorders
Symptom relief OngoingThis small study tests whether adding robot-assisted walking training to regular physiotherapy can improve body composition (like muscle and fat) and daily function in children with cerebral palsy or similar conditions. Nine children will each receive both standard physiotherapy …
Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Sailing therapy boosts resilience in kids with autism
Symptom relief OngoingThis study tests whether a nurse-led sailing program can improve resilience, self-esteem, and social skills in school-aged children with autism. About 184 children aged 7 to 12 will either take part in a 6-day sailing program or do simple craft activities. Researchers will compar…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Could a common supplement ease repetitive behaviors in kids with autism?
Symptom relief By invitation onlyThis study looks at whether N-acetylcysteine (NAC), a well-tolerated nutritional supplement, can reduce restricted and repetitive behaviors in children with autism spectrum disorder. About 144 children who previously took part in related NAC trials will receive the supplement and…
Phase 2/3 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Talking therapy shows promise for calming outbursts in kids with autism
Symptom relief By invitation onlyThis small pilot study at Yale University is testing a modified form of cognitive-behavioral therapy (CBT) for children with autism and intellectual disability who struggle with irritability, tantrums, and aggression. Up to 6 children aged with an IQ between 55 and 85 will receiv…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can exercise boost quality of life for people with intellectual disabilities?
Symptom relief By invitation onlyThis study compares two 8-week exercise programs for adults with intellectual disabilities who are currently sedentary. One group does traditional strength and endurance exercises, while the other plays sports like soccer and basketball. Researchers will measure changes in physic…
Sponsor: Universidad Católica San Antonio de Murcia • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can parent training tame autism behaviors and ease family stress?
Symptom relief OngoingThis study tests whether teaching parents of children with autism special behavior support techniques can reduce challenging behaviors and lower parenting stress. About 80 families in South Punjab, Pakistan, will take part in an 8-10 week program. The goal is to see if this appro…
Sponsor: Islamia University of Bahawalpur • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Beat the stress: drumming groups offer hope for parents of autistic kids
Symptom relief OngoingThis small study tests whether group drumming sessions can improve emotional well-being for parents of autistic children. Ten parents will take part in drumming groups and report changes in anxiety, depression, and feelings of belonging. The goal is to see if making music togethe…
Sponsor: Arizona State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could a cancer drug help kids with autism speak better?
Symptom relief OngoingThis study tests whether folinic acid (leucovorin), a drug already used to reduce side effects from chemotherapy, can improve language skills in children with autism spectrum disorder. Researchers will give the drug or a placebo to 56 children aged 5 to 17 for 12 to 24 weeks and …
Phase 2 • Sponsor: Southwest Autism Research & Resource Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Can sensory play empower parents and help kids with disabilities?
Symptom relief By invitation onlyThis study tests a program called MSE-PEACE, where parents and children with developmental disabilities (like autism or ADHD) attend 10 sensory sessions together. The goal is to see if it improves children's engagement and emotional control, and helps parents feel more confident …
Sponsor: National Cheng Kung University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New autism therapy trial aims to boost social skills and ease parent stress
Symptom relief OngoingThis study tests an 8-week program called SCERTS for children aged 3 to 6 with mild or moderate autism. The program focuses on improving social communication and emotional regulation while supporting parents. Researchers will measure changes in the child's social skills and the f…
Sponsor: Aisha Saleem • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can a sleep program help exhausted parents of kids with autism?
Symptom relief OngoingThis study compares a home-based, tailored sleep therapy (CBT-I) to a web-based version for 80 caregivers who have insomnia while caring for a child with autism. The goal is to see which approach is more acceptable and feasible for improving sleep and reducing caregiver burden. P…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a gentle nerve zap curb explosive outbursts in Prader-Willi syndrome?
Symptom relief OngoingThis phase 3 study tests a device that gently stimulates the vagus nerve through the skin (tVNS) to see if it can safely reduce temper outbursts in people with Prader-Willi syndrome. About 102 participants aged 10 to 40 will use either continuous or intermittent stimulation. The …
Phase 3 • Sponsor: Foundation for Prader-Willi Research • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New social skills class for autistic preschoolers shows promise in small trial
Symptom relief OngoingThis study tests a 16-week parent-assisted social skills program for 60 preschoolers with autism. Children learn through puppet shows, role-playing, and structured play, while parents get coaching. The goal is to improve social skills like making friends and playing with peers.
Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Can VR help kids with autism learn social cues?
Symptom relief By invitation onlyThis study tests a virtual reality program where children with autism watch avatars of themselves doing social behaviors like making eye contact and then practice those behaviors. 75 children aged 6-11 will be split into three groups: one gets the VR training, one gets standard t…
Sponsor: Inonu University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Can a simple drug calm catatonia in autistic teens? new study hopes so
Symptom relief OngoingThis pilot study tests whether benzodiazepines (midazolam and clonazepam) and, if needed, electroconvulsive therapy (ECT) can safely reduce catatonic symptoms in 30 adolescents aged 10–19 with profound autism. Participants first receive a midazolam challenge; those who respond th…
Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Horse therapy shows promise for kids with intellectual disabilities
Symptom relief OngoingThis study looks at whether a program involving horseback riding and horse care can help school-age children with intellectual disabilities. Researchers will measure stress (using heart rate, oxygen levels, and skin responses), balance, and daily living skills in 60 children. The…
Sponsor: Universidad Pontificia Comillas • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Rabbit suits and selfies: new app aims to get kids with autism moving
Symptom relief By invitation onlyThis study tests whether children with autism will do daily 5-10 minute exercises if they see themselves, other kids, or kids in rabbit suits in a mobile app. Twenty children and their parents will use the app for 8 weeks. Researchers will measure how long kids stick with the exe…
Sponsor: Linkoeping University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New therapy aims to tame emotional storms in kids with autism
Symptom relief OngoingThis study tests a group therapy program called Regulating Together for children with autism who struggle with intense emotions. The program teaches children and their caregivers skills to manage emotional reactions using techniques like cognitive behavioral therapy and mindfulne…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
AI job coach: ChatGPT tested to boost interview skills for autistic adults
Symptom relief By invitation onlyThis study tests whether ChatGPT can act as a job coach for adults with autism spectrum disorder (ASD). Thirty motivated adults aged 18-45 will use ChatGPT to build resumes, practice interviews, and discuss workplace social skills over one week. Researchers will measure changes i…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can a 6-Week zoom therapy help kids at risk for depression? st. louis schools test new approach
Symptom relief By invitation onlyThis study tests a 6-8 week caregiver-child therapy called THRIVE, delivered by school counselors via video or in school, to improve emotional and behavioral health in children aged 3-7 who are near the clinical threshold for mental health problems. THRIVE is compared to an onlin…
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Job interview training for autistic youth shows promise
Symptom relief By invitation onlyThis study tests whether an internet-based job interview training program (Virtual Interview Training) helps autistic young adults improve their interview skills and find jobs. About 200 participants will either use the training or continue with their usual services. Researchers …
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
VR headset training could sharpen focus in kids with autism and ADHD
Symptom relief By invitation onlyThis study tests whether virtual reality games can improve executive functions—like memory, focus, and planning—in 50 youth aged 8 to 18 with autism and ADHD. Participants will either play VR cognitive games or receive standard care. Researchers will compare thinking skills befor…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Gaming therapy aims to reduce repetitive hand movements in rett syndrome
Symptom relief OngoingThis study tests whether personalized computer games can help people with Rett syndrome use their arms more purposefully and reduce repetitive hand movements. Fourteen participants will play games that reward them for separating their hands and reaching for targets. The training …
Sponsor: Georgetown University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could magnetic pulses lift depression in autism?
Symptom relief OngoingThis study tests whether a type of brain stimulation called rTMS can reduce depression in people with autism. Twenty-four participants aged 13 to 26 will receive either real or sham (fake) stimulation to see if it helps. The goal is to find a new way to treat depression that hasn…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
School program aims to ease Kids' anxiety and depression
Symptom relief OngoingThis study tests a classroom program called the Kids' Empowerment Program (KEP) to help children ages 6 to 12 reduce symptoms of anxiety and depression. About 120 children will take part, with some starting the program right away and others later. The goal is to give kids practic…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New study tests tailored suicide prevention for autistic youth
Symptom relief By invitation onlyThis study compares two suicide prevention programs designed specifically for autistic youth aged 12-24. One program is a safety planning intervention (SPI-A), and the other adds follow-up contacts (SPI-A+). Researchers will track changes in suicidal thoughts and behaviors over a…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Parents as therapists: new autism trial tests Home-Based training
Symptom relief By invitation onlyThis study tests whether a parent training program called Project IMPACT can improve social communication and reduce autism symptoms in children aged 1.5 to 6.5 years. Eighty children will be randomly assigned to either the IMPACT group (parents do at least 10 hours of therapy pe…
Sponsor: University of Electronic Science and Technology of China • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New program aims to ease burden on families of kids with rare diseases
Symptom relief By invitation onlyThis study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …
Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Lifting weights, lifting spirits: new study tests strength training for down syndrome
Symptom relief OngoingThis study looks at whether a specially designed group resistance training program (called RESID) is safe, enjoyable, and helpful for adults with Down syndrome aged 20 to 45. The program includes exercises like lifting weights or using resistance bands. Researchers want to see if…
Sponsor: Saint John of God Intellectual Disability Services - Dublin South East • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a probiotic ease autism gut troubles?
Symptom relief OngoingThis study tests whether a probiotic called Saccharomyces boulardii can improve digestive health, immune function, nutrition, and behavior in children aged 5 to 12 with autism and a history of gut problems. Sixty-six children in Ecuador will take the probiotic for 4 months and th…
Phase 2 • Sponsor: Universidad San Francisco de Quito • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can a 5-Minute daily writing exercise ease stress for parents of autistic kids?
Symptom relief OngoingThis study tests a 14-day digital writing program designed to help parents of autistic individuals manage stress and improve mental health. Participants use a WeChat mini-program to write about their feelings and practice self-kindness for about 5 minutes each day. The trial incl…
Sponsor: University of Macau • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can a game app boost language in kids with autism?
Symptom relief By invitation onlyThis study tests a gamified app called MITA designed to improve language and thinking skills in children with autism aged 2 to 5. Sixty children will be randomly assigned to either use the app alongside their usual therapy or continue with standard care alone. The goal is to see …
Sponsor: ImagiRation, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can brain games at home help autistic kids think more flexibly?
Symptom relief OngoingThis pilot study tests whether a home-based computer training program can improve executive function (like shifting attention and controlling impulses) in autistic children aged 8 to 17. Fifteen participants will play two social-themed games for 30 minutes a day, five days a week…
Sponsor: Education University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Brain training for young autistic kids shows promise
Symptom relief OngoingThis study tests a computer-based training program designed to improve executive function (thinking, self-control, and memory) in 40 autistic children aged 5-7 in South Korea. Children will play games on a tablet and do activities with a coach over several sessions. Researchers w…
Sponsor: Korea University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can a simple test track ADHD med effects in kids with intellectual disability?
Symptom relief By invitation onlyThis study looks at whether a set of thinking and memory tests can detect changes caused by a stimulant medication in children aged 6 to 17 who have both intellectual disability and ADHD. About 68 participants will receive either the medication or a placebo, then switch after a b…
Phase 1 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Family talk therapy shows promise for autism – brain scans reveal changes
Symptom relief OngoingThis study tests whether a special type of family therapy, called Narrative Family Therapy, can improve how families with an autistic child communicate and function. Sixty-three families will either receive eight therapy sessions or play family games. Researchers will also use br…
Sponsor: University of Coimbra • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New program aims to ease autism transition for teens and parents
Symptom relief OngoingThis study tests a family-centered program called Transitioning Together / Juntos en la Transición, designed to help autistic youth (ages 14-21) and their parents navigate the move to adulthood. The program includes one individual family session and four group sessions covering t…
Sponsor: Boston Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Broccoli chemical could tame autism symptoms, small trial hopes
Symptom relief OngoingThis phase 2 trial tests whether sulforaphane, a compound found in broccoli, can improve core symptoms of autism. 48 males aged 13-30 with autism will receive either sulforaphane or a placebo for several weeks. Researchers will measure changes in behavior and social responsivenes…
Phase 2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Can online tools help families of children with autism?
Symptom relief OngoingThis study looks at whether telehealth tools can help families concerned about autism in their infants. Researchers are testing an online assessment tool and a set of video modules that teach parents strategies to support their child's communication. 80 families will be randomly …
Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Could a sleep drug improve social skills in autism?
Symptom relief OngoingThis study tests a drug called pitolisant in 62 boys and teens aged 6 to 17 with autism. The goal is to see if it improves social skills and behavior. Participants are randomly assigned to receive the drug or a placebo, and neither they nor the researchers know who gets which. Th…
Phase 2 • Sponsor: Bioprojet • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can CBD tame severe autism behaviors? new study investigates
Symptom relief OngoingThis study tests whether cannabidiol (CBD) can reduce severe behavior problems like aggression, self-harm, and repetitive actions in children with autism. About 42 boys aged 7-14 with severe autism and daily behavioral issues will receive both CBD and a placebo at different times…
Phase 2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a 6-week online class for parents boost communication in toddlers with autism signs?
Symptom relief OngoingThis study tests a 6-week virtual group program that teaches parents strategies to encourage their toddler's vocalizations and shared smiling. The program is for children aged 12-42 months who have early signs or a diagnosis of autism or related social communication challenges. R…
Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Robot suit helps kids with movement disorders take steps at home
Symptom relief OngoingThis study tests a wearable robotic exoskeleton called EXPLORER in 15 children with movement problems from conditions like cerebral palsy. The goal is to see if it helps them walk better in their everyday environments, such as home and the community. The study focuses on safety, …
Sponsor: MarsiBionics • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Brain zaps may tame sensory overload in kids with autism
Symptom relief By invitation onlyThis study tests whether a non-invasive brain stimulation technique called cTBS can improve how children with autism (ages 6-12) combine what they see and hear. Forty children will receive either real or sham stimulation over 10 sessions. Researchers will use brain scans, genetic…
Sponsor: Neurolab Plus • Aim: Symptom relief
Last updated Jun 26, 2026 19:17 UTC
-
Brain zaps for ADHD? new study tests iTBS in children
Symptom relief By invitation onlyThis study tests whether a non-invasive brain stimulation technique called iTBS can improve attention and self-control in children aged 6 to 12 with ADHD. Over two weeks, 40 children will receive either real or sham stimulation, and researchers will measure changes in attention u…
Sponsor: Neurolab Plus • Aim: Symptom relief
Last updated Jun 26, 2026 19:15 UTC
-
Laughter yoga tested as a tool to ease autism anxiety and parent stress
Symptom relief OngoingThis pilot study explores whether laughter yoga can reduce depression and anxiety in children with autism spectrum disorder (ages 8–12) and lower parenting stress for their parents. 66 families will either take part in laughter yoga sessions or be placed on a waiting list. The st…
Sponsor: LAM Chung Yan Hemio • Aim: Symptom relief
Last updated Jun 26, 2026 19:11 UTC
-
New nasal spray aims to tame relentless hunger in rare genetic disorder
Symptom relief OngoingThis Phase 3 trial tests a nasal spray called carbetocin to reduce the intense, constant hunger (hyperphagia) in people with Prader-Willi syndrome. The study involves 170 participants aged 5 to 30 and lasts 12 weeks. Caregivers will rate changes in hunger-related behaviors using …
Phase 3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 16:16 UTC
-
Brain training may boost social skills in kids with autism
Symptom relief By invitation onlyThis study tests a brain training method that combines EEG and fNIRS to help autistic children aged 8 to 12 improve attention, emotion control, and social skills. Thirty children will receive neurofeedback sessions and complete thinking and behavior assessments. The goal is to se…
Sponsor: Education University of Hong Kong • Aim: Symptom relief
Last updated Jun 26, 2026 15:21 UTC
-
Broccoli extract studied for autism – but study never started
Symptom relief CancelledThis study planned to test whether sulforaphane, a compound found in broccoli, could improve social skills and behavior in people with autism spectrum disorder (ASD). Researchers aimed to enroll 50 people with ASD aged 12–34 and 30 healthy volunteers, giving the ASD group sulfora…
Sponsor: Jian-Jun Ou • Aim: Symptom relief
Last updated Jun 26, 2026 14:19 UTC
-
Robot arm aims to give independence back at mealtime
Symptom relief OngoingThis study tests a robotic feeding device called Obi for people who cannot use their arms to eat on their own. About 50 participants, including patients, caregivers, and healthcare providers, will use the device at home or in care settings for one week. Afterward, they will fill …
Sponsor: Desin LLC • Aim: Symptom relief
Last updated Jun 26, 2026 12:48 UTC
-
Gut bacteria may hold clues to dozens of diseases
Knowledge-focused PausedResearchers are sequencing the gut microbiomes of people with a wide range of conditions, from autism and Alzheimer's to Crohn's disease and multiple sclerosis, to see whether bacterial patterns differ by disease. The study also enrolls healthy participants for comparison. By mat…
Sponsor: ProgenaBiome • Aim: Knowledge-focused
Last updated Sep 21, 2026 14:00 UTC
-
Why do some children with autism struggle with balance?
Knowledge-focused By invitation onlyResearchers at the University of Management and Technology Sialkot are studying how motor coordination relates to postural stability in children with autism spectrum disorder. The study includes 30 children aged 5 to 12 who can stand and walk without help. Parents answer a questi…
Sponsor: University of Management and Technology Sialkot Pakistan • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can peer mentors help young adults with disabilities feel less lonely?
Knowledge-focused By invitation onlyThis study looks at whether young adults (ages 18-27) with mild to moderate intellectual or developmental disabilities feel less lonely and more connected when they learn travel skills from a peer who also has a disability, compared to learning from regular staff. About 325 parti…
Sponsor: Temple University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Smart sensors could revolutionize rett syndrome monitoring
Knowledge-focused OngoingThis study tests whether wearable biosensors can accurately track symptoms like heart rate, breathing, sleep, and movement in people with Rett syndrome. Up to 30 participants will use the devices at home for 9 weeks and also undergo one overnight sleep study in the clinic. The go…
Sponsor: Rett Syndrome Research Trust • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Epidiolex liver check: is Long-Term use safe?
Knowledge-focused OngoingThis study follows 154 people taking Epidiolex (cannabidiol) for seizures caused by Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. Researchers will monitor for signs of chronic liver injury and fibrosis over time using blood tests and liver scans. The go…
Phase 4 • Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New program aims to help autistic adults find and keep jobs
Knowledge-focused OngoingThis study tests a program called Individual Placement and Support for Autism (IPS-AUT) to help autistic adults ages 18-40 find and keep competitive jobs. Researchers will work with employment agencies to train staff and track job outcomes, satisfaction, and thinking skills. The …
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Can we decode the hidden physical health struggles of autism?
Knowledge-focused OngoingThis study investigates the link between autism and physical symptoms like gastrointestinal issues, autoimmune diseases, and heart problems. Researchers will compare autistic individuals, people with anxiety or depression, and healthy controls to understand how these symptoms are…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Counting the uncounted: a nationwide look at two rare epilepsies
Knowledge-focused CancelledThis observational study aims to measure how many people in Portugal have Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS), two rare and severe forms of epilepsy. Researchers will review existing medical records from about three public hospitals to estimate the percentage of…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Can a parent support group help teens with both autism and anorexia?
Knowledge-focused OngoingThis study looks at how parents of autistic young people (ages 12-18) with anorexia nervosa make sense of a group intervention designed for them. Researchers want to understand how parents interpret the concepts from the group and apply them to daily family life, and how they see…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can Early-Life factors steer preterm and term infant health?
Knowledge-focused OngoingThis study follows mother-infant pairs from birth to 24 months to see how early nutrition, environmental exposures, and family factors relate to growth, development, and allergies in preterm and term infants. Researchers will use questionnaires and biological samples to examine h…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can tracking a rare genetic syndrome unlock its mysteries?
Knowledge-focused OngoingThis study follows people with Phelan-McDermid syndrome, a rare genetic condition linked to autism and intellectual disability, to map how the syndrome unfolds over two years. Researchers will measure changes in thinking, behavior, language, and motor skills, and use brain imagin…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
EEG clues may reveal who benefits from seizure drug
Knowledge-focused By invitation onlyThis study looks at whether specific brain wave patterns on an EEG can predict how well the drug fenfluramine works for people with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy. Researchers will follow 20 children and adults aged 2 to 35 who are already taking fenflur…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could air pollution before birth raise ADHD risk? new brain scan study aims to find out
Knowledge-focused By invitation onlyThis study looks at whether air pollution exposure before birth is linked to ADHD risk in Puerto Rican children. Researchers will use brain scans (MRI) in 182 kids aged 6-11 to examine brain areas tied to attention. They also want to see if inflammation during pregnancy or sleep …
Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can a gene mutation explain Autism's many faces?
Knowledge-focused OngoingThis study follows individuals with autism who carry a PTEN gene mutation, along with comparison groups, to track changes in thinking, language, and behavior over time. Researchers will also collect blood samples and medical data to build a large database for future studies. The …
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Brain imaging may unlock early clues to autism in tuberous sclerosis
Knowledge-focused OngoingThis study investigates whether advanced brain imaging and electrical recordings can predict the presence and severity of autism spectrum disorder (ASD) and intellectual disability (ID) in people with tuberous sclerosis complex (TSC). Researchers will follow participants over tim…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Listening to the brainstem: a new window into autism?
Knowledge-focused OngoingThis study looks at auditory brainstem evoked potentials (BAEPs) — electrical signals from the brain in response to sound — in children with autism spectrum disorder (ASD). By comparing these signals to those of children with other neuropsychiatric conditions, researchers hope to…
Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can mapping a rare Gene's effects pave the way to targeted epilepsy therapies?
Knowledge-focused OngoingThis study follows children aged 6 to 21 who have a CNKSR2 gene mutation, which can cause epilepsy, language difficulties, and intellectual disability. Researchers will use brain scans, EEGs, and developmental tests to track how the condition changes over time. The goal is to cre…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
How do children with autism process social cues? large study aims to find out
Knowledge-focused OngoingThis study compares social cognitive abilities—like recognizing emotions and understanding others' thoughts—in children with autism versus typically developing children aged 2.5 to 14 years. Researchers will use behavioral tasks and eye-tracking to map developmental patterns. The…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New study tests two ways to empower parents of kids with intellectual disabilities
Knowledge-focused OngoingThis study compares two programs for parents of teens and young adults (ages 11-27) with intellectual or developmental disabilities. One program teaches parents how to advocate for their child's health, while the other connects them with other parents for shared learning. Researc…
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists hunt for genetic clues to autism
Knowledge-focused OngoingThis study aims to uncover the genetic and environmental factors behind autism spectrum disorders (ASD), including autism, Asperger's syndrome, and PDD. Researchers will analyze gene expression in 240 participants aged 18 months and older who have an ASD diagnosis. The goal is to…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain scans reveal overlap in social thinking in autism and schizophrenia
Knowledge-focused OngoingThis study uses brain scans and behavioral data from 267 adults (80 with autism, 79 with schizophrenia, and 108 healthy controls) to explore shared brain activity patterns related to social thinking. No new treatments are given; researchers analyze existing data to understand how…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
AI tablet rehab gets a Kid-Friendly makeover
Knowledge-focused OngoingThis study works with children aged 7 to 16 who have borderline intellectual disorder, their families, and experts to improve a tablet-based AI program that helps with thinking and language skills. Researchers are collecting feedback through interviews and workshops to make the p…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New tool aims to fairly assess Autism-Related risks in court
Knowledge-focused OngoingThis study is not a treatment trial. It aims to translate and test a new assessment tool (FARAS-IT) for adults with autism who are involved in the Italian criminal justice system. Researchers will enroll 100 adults with autism, including those in forensic psychiatric care, those …
Sponsor: University of Bari • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can a simple toolkit boost autism therapy? 600 families join study
Knowledge-focused By invitation onlyThis study tests a toolkit called PEACE, designed to help early intervention providers coach parents of young children with autism. Researchers will enroll 200 providers and 400 parent-child dyads to see if the toolkit improves how providers support families. The goal is to make …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can video coaching help parents connect with autistic toddlers?
Knowledge-focused OngoingThis study tests a therapy where parents of children with autism (ages 1.5 to 3) get video feedback to help them better understand and respond to their child's signals. The goal is to improve joint attention, a key skill for social communication. Twenty-seven families will be ran…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists track rare dystonia to map its genetic roots
Knowledge-focused OngoingThis study is observing up to 198 people with rapid-onset dystonia-parkinsonism (RDP) or related genetic mutations. Researchers aim to identify affected individuals, document how common the disease is, and track its progression over time. Participants undergo assessments of sympt…
Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Vision training may boost brain and body health in intellectual disability
Knowledge-focused CancelledThis study aimed to see if a 16-week perceptual-vision training program could improve thinking skills (like focus) and physical fitness (balance, strength, agility) in adults aged 40-70 with mild intellectual disability. Participants were to be split into training, training-then-…
Sponsor: Università degli Studi dell'Insubria • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Brain activity study aims to unlock imitation challenges in autism
Knowledge-focused OngoingThis study looks at why children with autism spectrum disorder (ASD) have trouble imitating others. Researchers will have 201 children aged 8 to 12 perform imitation tasks while recording brain activity with EEG. The goal is to pinpoint where the breakdown happens, which could im…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New registry aims to unlock secrets of rare CDKL5 disorder
Knowledge-focused PausedThis study creates a registry for up to 500 people with CDKL5 Deficiency Disorder (CDD), a rare genetic condition that causes seizures and developmental delays. Patients and their caregivers will provide information about symptoms, treatments, and quality of life over several yea…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can melatonin fix sleep problems in autism? new study investigates brain waves
Knowledge-focused OngoingThis study looks at whether melatonin, a common sleep aid, can improve sleep spindles—special brain waves that help with sleep and attention—in 30 children with autism aged 12-18. Researchers want to understand why sleep and sensory issues happen in autism and test if melatonin c…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Tennis tech boost for special needs teens
Knowledge-focused OngoingThis study looked at whether a real-time pose recognition system could help 30 teenagers with mild to moderate intellectual disabilities learn tennis skills more accurately and quickly than traditional coaching. Participants were split into two groups: one used the technology dur…
Sponsor: Burdur Mehmet Akif Ersoy University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Can a nasal spray help autism symptoms? new study investigates
Knowledge-focused By invitation onlyThis study follows about 12 children and young adults (ages 4 to 21) with autism who are already using intranasal insulin as part of their regular care. Researchers want to see if this treatment is safe and if it helps with social skills, communication, and behavior over 6 months…
Sponsor: Healing Hope International • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New study observes patients getting nasal stem cell therapy for brain conditions
Knowledge-focused By invitation onlyThis observational study follows 36 people with neurologic conditions like traumatic brain injury, cerebral palsy, multiple sclerosis, or Alzheimer's who are already receiving intranasal MuSE stem cell or exosome therapy as part of their routine care. Researchers track safety and…
Sponsor: Healing Hope International • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Sleep apnea treatment may help blood pressure, especially in the very sleepy
Knowledge-focused OngoingThis study looks at whether treating obstructive sleep apnea (OSA) with a breathing device (CPAP) lowers blood pressure more in people who are very sleepy compared to those who are not. Researchers will analyze data from about 10,000 adults with OSA from previous studies. The goa…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Can a simple play technique boost language in babies at risk for autism?
Knowledge-focused CancelledThis pilot study explores a new language intervention called Milieu Teaching-AV for infant siblings of autistic children, who are at higher risk for autism or language delays. The intervention teaches caregivers to encourage babies to look at the mouth during play, aiming to impr…
Sponsor: Father Flanagan's Boys' Home • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Home visits for moms may boost child development and Well-Being
Knowledge-focused By invitation onlyThis study tests whether a home visiting program for mothers facing stress or past trauma can improve their mental health and their child's emotional and behavioral development. Researchers will follow 352 mother-child pairs from pregnancy until the child is 18 months old. They w…
Sponsor: IRCCS Eugenio Medea • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Can online Check-Ins help track autism care? small study aims to find out
Knowledge-focused By invitation onlyThis pilot study will test whether an online assessment battery is practical for children with autism who are receiving complementary and integrative healthcare. Twenty children aged 3-12 will complete online questionnaires and check-ins with their practitioners. The main goal is…
Sponsor: Life University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Gut check: could probiotics help kids with autism handle stress?
Knowledge-focused OngoingThis study looks at how the gut microbiome (the bacteria in our intestines) is linked to stress in children with autism or those who have experienced trauma. Researchers will give 75 children, ages 4 to 7, a probiotic powder for 4 weeks and measure changes in their gut bacteria a…
Sponsor: Nova Southeastern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Can a common antidepressant rewire autism brains? tiny study hopes to find out
Knowledge-focused By invitation onlyThis small study will give 5 teens with autism a single dose of escitalopram (Lexapro) or a placebo, then scan their brains to see how the drug affects networks linked to rigid thinking and repetitive behaviors. The goal is to understand whether this medication might help with in…
Phase 2 • Sponsor: Kathryn Unruh • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Brain training for autism: can therapy rewire learning in teens?
Knowledge-focused OngoingThis study looks at whether a group therapy program called Unstuck & On Target can improve flexibility and learning in 64 teens with autism aged 14-18. Researchers will use brain scans (MRI) to see if the therapy changes how the brain processes new information. The goal is to und…
Sponsor: Children's National Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Vagus nerve study for autism withdrawn before starting
Knowledge-focused CancelledThis study planned to test vagus nerve stimulation (VNS) in children and adults with autism and developmental disabilities to see if it could improve behavior, thinking, and body rhythms. Participants would have chosen 1 to 3 months of daily VNS and completed monthly check-ins. T…
Sponsor: New York State Institute for Basic Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New program aims to boost independence for youth with disabilities
Knowledge-focused By invitation onlyThis study tests a program called the Community Mobility Planning Process (CMPP) for young adults aged 16-30 with mild to moderate intellectual disabilities. Over 8 weeks, participants work with support staff on activities to plan how to get around their community more independen…
Sponsor: Temple University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Eye-Tracking study seeks to uncover hidden attention clues in ADHD and autism
Knowledge-focused OngoingThis study looks at how eye movements, specifically eye vergence (how eyes work together for depth perception), relate to attention in people with ADHD and autism. Researchers will use computer-based eye-tracking tasks with 200 children and adults to see if these eye patterns can…
Sponsor: Elizabeth Kilbey • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Brain wave mapping study halted before it began
Knowledge-focused CancelledThis study planned to use high-frequency brain signals to locate important brain areas and understand conditions like epilepsy, migraine, and ADHD. It aimed to create a large database of brain activity in people aged 1 day to 69 years. However, the study was withdrawn before any …
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Brain zaps may boost social skills in autism
Knowledge-focused OngoingThis study tests whether a non-invasive brain stimulation technique called repetitive Transcranial Magnetic Stimulation (rTMS) can change how adults with autism process social information. Researchers will measure brain responses with EEG and eye-tracking before and after stimula…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Tiny brain tracker could help spot hidden seizures in people with intellectual disabilities
Knowledge-focused OngoingThis study looks at whether a tiny device placed under the scalp can safely and comfortably track seizures in adults with mild to moderate intellectual disability and epilepsy. Nine participants will wear the monitor for up to 6 months, and researchers will compare the device's r…
Sponsor: University of Plymouth • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Smart sensors could spot motor delays in babies early
Knowledge-focused OngoingThis study tests whether wearable sensors and video recordings can help detect motor development problems in infants from birth to 24 months. Researchers will compare data from these devices with standard clinical tests. The goal is to create a more precise and automated way to i…
Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New study links mitochondrial issues to autism subtypes
Knowledge-focused OngoingResearchers at Arkansas Children's Hospital are studying how mitochondria work in children with autism spectrum disorder. They aim to identify distinct patterns of mitochondrial dysfunction that may relate to developmental delays. The study involves up to 5 visits with blood draw…
Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to predict sudden death in severe epilepsy
Knowledge-focused OngoingThis study looks at how repeated seizures affect breathing and heart function in people with Dravet syndrome, a severe form of epilepsy. Researchers will monitor 92 children and adults for 24-48 hours using video, brain wave, heart, and breathing recordings. The goal is to find c…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Brain scans aim to unlock secrets of autism and depression
Knowledge-focused By invitation onlyThis study uses brain scans and magnetic stimulation to compare brain activity in 160 adults with autism, depression, both, or neither. Researchers want to understand how brain inflammation and the balance of excitation and inhibition relate to social and emotional symptoms. No t…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Pregnancy painkillers linked to child behavior risks?
Knowledge-focused By invitation onlyThis study looks at whether taking common painkillers like paracetamol or ibuprofen during pregnancy can affect a child's brain development, behavior, and language skills. Researchers will follow 685 children aged 2 to 4 years whose mothers were part of an earlier study on painki…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Massive study digs into Autism's genetic roots
Knowledge-focused OngoingThis study is collecting genetic information and observable traits from 1500 people with autism and their families. The goal is to better understand how genes relate to autism. Participants must be at least 18 months old and have an autism diagnosis or a related genetic finding.
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Can early reading help kids who Can't speak? new study investigates
Knowledge-focused OngoingThis study looks at whether special reading lessons can help young children (ages 4-8) with intellectual disabilities who use pictures or devices to communicate. Researchers will compare different timing and combinations of reading programs in kindergarten and first grade. The go…
Sponsor: Ostfold University College • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Can better training help therapists deliver autism care more effectively?
Knowledge-focused By invitation onlyThis study looks at whether a special training program called TEAMS helps therapists and teachers use proven autism therapies more effectively. Researchers will work with about 1206 people, including program leaders, providers, and parents of children with autism. The goal is to …
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New framework aims to prevent medication errors in vulnerable group
Knowledge-focused OngoingThis study works with 110 adults who have intellectual or developmental disabilities and receive care from a Norwegian municipality. The goal is to create better routines and digital tools to make sure they get the right medicines safely. Researchers will review each person's med…
Sponsor: Vestvagoy Municipality • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New online sex ed program aims to empower autistic adults in korea
Knowledge-focused OngoingThis study is testing a new online sex education program called 'Our Love, Our Style' for autistic young adults in South Korea. The program covers relationships, consent, and sexual health over 10 weekly sessions. Researchers want to see if it improves knowledge and relationship …
Sponsor: Korea University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Smartwatches may help measure autism treatment effects
Knowledge-focused By invitation onlyThis small pilot study aims to see if digital biomarkers—like heart rate and movement tracked by a watch—can help measure changes in autism symptoms during treatment with sulforaphane, a compound found in vegetables. Ten males aged 13-30 with autism who previously took part in a …
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Navajo family program aims to bridge autism support gap
Knowledge-focused OngoingThis pilot trial tests a culturally adapted parent training program for Navajo families of children with autism or developmental disabilities. About 29 parents will be randomly assigned to join the program right away or after a wait. The program is led by trained Navajo Family Ad…
Sponsor: Northern Arizona University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:46 UTC
-
Autism study examines posture and balance in kids
Knowledge-focused By invitation onlyThis study looks at spinal posture, balance, and ankle muscle tightness in children with autism compared to typically developing children. Researchers will measure these physical traits using tools like the Spinal Mouse and balance tests. The goal is to understand if children wit…
Sponsor: Abant Izzet Baysal University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:39 UTC